Sex (male, n (%)) | 143 (49) |
Age (y)* | 46 (11.2) [19–73] |
Source of infection (n (%)) |
Blood transfusion | 70 (24) |
Intravenous drug use | 91 (31) |
Unknown | 129 (45) |
Duration of infection (y)* | 21 (7.4) [5–52] |
Body mass index (kg/m2)* | 24 (3.8) [16–38] |
Alcohol consumption (n (%)) |
Absent | 190 (66) |
Present | 91 (31) |
Unknown | 9 (3) |
Tobacco consumption (n (%)) |
Absent | 154 (53) |
Present | 117 (40) |
Unknown | 19 (7) |
ALT (IU/l) (median)* | 97 (84.4) [12–691] |
Glycaemia (mmol/l)* | 5.3 (1.7) [3.2–19.4] |
Cholesterol (mmol/l)* | 4.8 (1.0) [2–9] |
Triglycerides (mmol/l)* | 1.3 (0.8) [0.3–4.3] |
HCV genotype (n (%)) |
1 | 139 (48) |
3 | 51 (18) |
Other | 59 (20) |
Unknown | 41 (14) |